About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Change of Registered Office and Principal Place of Business
January 20, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter – December 2016
Next Post
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
Related Posts
Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete
December 12, 2016
Quarterly Activities Report and 4C to 31 March 2022
April 29, 2022
April 29, 2022
Receipt of R&D Tax Incentive
November 8, 2018